Insmed Inc (INSM)
68.15
-0.17
(-0.25%)
USD |
NASDAQ |
Nov 04, 16:00
68.45
+0.30
(+0.44%)
After-Hours: 20:00
Insmed 1 Year Total Returns (Daily): 173.4% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 173.4% |
October 31, 2024 | 168.5% |
October 30, 2024 | 195.4% |
October 29, 2024 | 197.1% |
October 28, 2024 | 201.3% |
October 25, 2024 | 178.8% |
October 24, 2024 | 186.3% |
October 23, 2024 | 188.9% |
October 22, 2024 | 193.8% |
October 21, 2024 | 188.2% |
October 18, 2024 | 194.9% |
October 17, 2024 | 189.0% |
October 16, 2024 | 205.6% |
October 15, 2024 | 201.5% |
October 14, 2024 | 203.2% |
October 11, 2024 | 197.2% |
October 10, 2024 | 189.0% |
October 09, 2024 | 185.4% |
October 08, 2024 | 192.0% |
October 07, 2024 | 188.5% |
October 04, 2024 | 199.3% |
October 03, 2024 | 193.6% |
October 02, 2024 | 187.8% |
October 01, 2024 | 188.6% |
September 30, 2024 | 189.1% |
Date | Value |
---|---|
September 27, 2024 | 179.8% |
September 26, 2024 | 182.8% |
September 25, 2024 | 182.1% |
September 24, 2024 | 177.5% |
September 23, 2024 | 174.4% |
September 20, 2024 | 190.8% |
September 19, 2024 | 184.9% |
September 18, 2024 | 174.5% |
September 17, 2024 | 175.3% |
September 16, 2024 | 175.2% |
September 13, 2024 | 183.9% |
September 12, 2024 | 174.5% |
September 11, 2024 | 174.6% |
September 10, 2024 | 172.5% |
September 09, 2024 | 173.5% |
September 06, 2024 | 168.8% |
September 05, 2024 | 176.5% |
September 04, 2024 | 232.4% |
September 03, 2024 | 223.8% |
August 30, 2024 | 246.3% |
August 29, 2024 | 253.2% |
August 28, 2024 | 254.0% |
August 27, 2024 | 253.1% |
August 26, 2024 | 244.4% |
August 23, 2024 | 256.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-51.68%
Minimum
Mar 23 2020
284.8%
Maximum
Jul 11 2024
28.19%
Average
5.94%
Median
May 15 2023
1 Year Total Returns (Daily) Benchmarks
Fulcrum Therapeutics Inc | -16.20% |
Alnylam Pharmaceuticals Inc | 61.30% |
Eli Lilly and Co | 42.91% |
Bioventus Inc | 257.0% |
Entrada Therapeutics Inc | 13.55% |